Tacalyx
PrivateLast Round
Seed
Apr 29, 2026
Total Funding Raised
$28M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Tacalyx is a biotechnology company that develops novel anticancer therapeutics targeting Tumor Associated Carbohydrate Antigens (TACAs).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tacalyx Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Tacalyx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 29, 2026 | ||||
| Seed | Jun 11, 2024 | ||||
| Seed | Sep 25, 2019 |
Key People
Founding team and executive leadership
Tacalyx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boehringer Ingelheim | Seed |
| Idinvest Partners | Seed |
| Eurazeo Investment Manager | Seed |
| Thuja Capital | Seed |
| Max Planck Society for the Advancement of Science | Seed |
| Boehringer Ingelheim Venture Fund | Seed |
| Creathor Venture | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 29, 2026
$12M round with participation from Eurazeo and Boehringer Ingelheim.
- Feb 16, 2026
Grew 23% QoQ from 13 to 16 employees.
Tacalyx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tacalyx's valuation, stock price, and market status.